Skip to content

Clinical trials

Completed Polyradiculoneuropathy, Chronic Inflammatory Demyelinating trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Polyradiculoneuropathy, Chronic Inflammatory Demyelinating Status: Completed Country / region: United States Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20042
20051
20091
20111
20122
20131
20142
20152
20161
20192
20201
20212
20221
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed21

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Baxalta now part of Shire2
CSL Behring2
argenx2
Biogen1
Bioverativ, a Sanofi company1
Grifols Therapeutics LLC1
National Institute of Neurological Disorders and Stroke (NINDS)1
Northwestern University1
Novartis Pharmaceuticals1
Oregon Health and Science University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating21
Demyelinating Diseases2
Polyradiculoneuropathy2
Acquired Immunodeficiency Syndrome1
Alopecia Areata1
Anemia, Sickle Cell1
Arthritis, Psoriatic1
Asthma1
Autoimmune Diseases1
Autoimmune Diseases of the Nervous System1

Trials

Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.